Free Trial

Coya Therapeutics (COYA) SEC Filings & 10K Form

Coya Therapeutics logo
$6.26 +0.49 (+8.39%)
Closing price 07/3/2025 03:52 PM Eastern
Extended Trading
$6.05 -0.22 (-3.50%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Coya Therapeutics SEC Filings

DateFilerForm TypeView
07/01/2025
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
4:00 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
4:05 PM
Coya Therapeutics (Filer)
Form DEFA14A
05/16/2025
4:10 PM
Coya Therapeutics (Filer)
Form ARS
05/13/2025
7:07 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
7:14 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
4:07 PM
Coya Therapeutics (Filer)
Form 10-K/A
03/18/2025
7:26 AM
Coya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
7:20 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
7:35 AM
Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:00 AM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
Swaminathan Arun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:31 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
11/29/2024
3:15 PM
Coya Therapeutics (Filer)
Form 424B3
11/20/2024
4:15 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
5:08 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
2:37 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/06/2024
7:06 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:02 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:02 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:27 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:42 AM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:42 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:08 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
8:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:04 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:13 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Click here to see the Tesla shock that could blindside everyone.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COYA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners